Three non-invasive treatment options of superficial basal cell carcinoma: Photodynamic therapy (PDT) [Metvix] vs imiquimod [Aldara] vs 5-fluorouracil [Efudix]: TTOP-sBCC trial.

Trial Profile

Three non-invasive treatment options of superficial basal cell carcinoma: Photodynamic therapy (PDT) [Metvix] vs imiquimod [Aldara] vs 5-fluorouracil [Efudix]: TTOP-sBCC trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 May 2013

At a glance

  • Drugs Imiquimod (Primary) ; Fluorouracil
  • Indications Basal cell cancer
  • Focus Therapeutic Use
  • Acronyms TTOP-sBCC
  • Most Recent Events

    • 14 May 2013 Results published in the Lancet Oncology.
    • 17 Mar 2012 Additional lead trial centre identified as reported by EudraCT.
    • 02 Mar 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top